In vitro and
in vivo antimycobacterial activities of new quinolones, norfloxacin (NFLX), ofloxacin (OFLX) and ciprofloxacin (CPFX) were studied and the following results were obtained.
With regard to the in vitro activity of the quinolones against various pathogenic mycobacteria evaluated by agar dilution method, it was found that these quinolones were appreciably active against
M. tuberculosis (MIC
90=0.83.13μg/ml),
M. kansasii (for OFLX and CPFX 1.6μg/ml),
M. marinum (for CPFX, 0.8, μ/ml) and
M. fortuitum (0.2-0.8 μg/ml), while they showed only a low activity against
M. scrofulaceum, M. aviumcomplex and
M. chelonae. The activity was highest in CPFX, intermediate in OFLX and lowest in NFLX.
Antimicrobial activity of 1 μg/ml of the quinolones against M. fortuitum growing in Dubos Tween-albumin medium or resting in phosphate buffered saline was studied. All agents showed antimicrobial activity against the organisms in both cases, whereas NFLX showed only a weak bacteriostatic action on the organisms growing in Dubos Tween albumin medium. The activity of CPFX was higher than that of OFLX.
OFLX and CPFX showed the therapeutic effects against experimental murine infection due to
M. fortuitum when each agent was given orally to mice 24h after infection at the dose of 1 mg per mouse once daily, 6 times a week, for 4 weeks, but NFLX did not.
抄録全体を表示